UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000054547 |
|---|---|
| Receipt number | R000062311 |
| Scientific Title | Wish and preference of adolescents with cancer at end of life: a scoping review |
| Date of disclosure of the study information | 2024/06/03 |
| Last modified on | 2025/12/05 12:52:29 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Wish and preference of adolescents with cancer at end of life: a scoping review
Acronym
Wish and preference of adolescents with cancer at end of life: a scoping review
Scientific Title
Wish and preference of adolescents with cancer at end of life: a scoping review
Scientific Title:Acronym
Wish and preference of adolescents with cancer at end of life: a scoping review
Region
| Japan |
Condition
Condition
cancer
Classification by specialty
| Pediatrics | Nursing |
Classification by malignancy
Malignancy
Genomic information
NO
Objectives
Narrative objectives1
To identify wish and preference of adolescents with cancer at end of life
Basic objectives2
Others
Basic objectives -Others
To map wish and preference which was revealed of adolescents with cancer at end of life
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
Wish and preference of adolescents with cancer at end of life
Key secondary outcomes
Base
Study type
Others,meta-analysis etc
Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 13 | years-old | <= |
Age-upper limit
| 24 | years-old | >= |
Gender
Male and Female
Key inclusion criteria
1)patients with cancer (more than or equal to 80%)
2)expressing wish and preference by patient
3)writing in English or Japanese
Key exclusion criteria
1)Duplicate publications
2)Conference proceedings
3)(less than 13year and more than 24year) more than 20percents
Target sample size
Research contact person
Name of lead principal investigator
| 1st name | Moe |
| Middle name | |
| Last name | Nakagawa |
Organization
Mie University
Division name
Graduate School of Medicine
Zip code
514-8507
Address
2-174 Edobashi, Tsu,Mie
TEL
0592316251
324M105@m.mie-u.ac.jp
Public contact
Name of contact person
| 1st name | Moe |
| Middle name | |
| Last name | Nakagawa |
Organization
Mie University
Division name
Graduate School of Medicine
Zip code
5148507
Address
2-174 Edobashi, Tsu,Mie
TEL
0592316251
Homepage URL
324M105@m.mie-u.ac.jp
Sponsor or person
Institute
Mie University
Institute
Department
Personal name
Funding Source
Organization
None
Organization
Division
Category of Funding Organization
Self funding
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
N/A
Address
N/A
Tel
N/A
N/A
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2024 | Year | 06 | Month | 03 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
0
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
No longer recruiting
Date of protocol fixation
| 2024 | Year | 06 | Month | 03 | Day |
Date of IRB
| 2024 | Year | 06 | Month | 03 | Day |
Anticipated trial start date
| 2024 | Year | 06 | Month | 03 | Day |
Last follow-up date
| 2025 | Year | 12 | Month | 31 | Day |
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
1)Data sources and search strategy
We will conduct a scoping review to identify wish and preference of adolescents with cancer at end of life. This scoping review will be conducted using the electronic databases, PubMed, CINAHL, CENTRAL, Medical Journal Web Edition with the keywords "adolescent," "cancer," "wish or preference", "end of life" for all literature reported.
2)Selection of studies in included studies
Two review authors will independently check to ensure that studies meet the inclusion criteria. Any discrepancies in study selection will be resolved by discussion or discussion with a third author.
Management information
Registered date
| 2024 | Year | 06 | Month | 03 | Day |
Last modified on
| 2025 | Year | 12 | Month | 05 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000062311
